These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3266670)
21. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine. Wong DT; Bymaster FP Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):41-51. PubMed ID: 6974884 [TBL] [Abstract][Full Text] [Related]
22. Fluoxetine and 8-OH-DPAT in the lateral septum enhances and impairs retention of an inhibitory avoidance response in rats. Lee EH; Lin WR; Chen HY; Shiu WH; Liang KC Physiol Behav; 1992 Apr; 51(4):681-8. PubMed ID: 1534416 [TBL] [Abstract][Full Text] [Related]
23. Clinical and experimental studies on fluoxetine: effects on serotonin uptake. Butler J; Leonard BE Int Clin Psychopharmacol; 1990 Jan; 5(1):41-8. PubMed ID: 2332607 [TBL] [Abstract][Full Text] [Related]
25. Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo. Fuller RW; Snoddy HD; Krushinski JH; Robertson DW Neuropharmacology; 1992 Oct; 31(10):997-1000. PubMed ID: 1279447 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections. Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137 [TBL] [Abstract][Full Text] [Related]
27. Hypothalamic TRH mediates anorectic effects of serotonin in rats. Chávez J; Alcántara-Alonso V; García-Luna C; Soberanes-Chávez P; Grammatopoulos D; de Gortari P eNeuro; 2022 May; 9(3):. PubMed ID: 35545425 [TBL] [Abstract][Full Text] [Related]
28. Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice. Yu Z; Ohba M; Nakamura M; Sasano T; Ono M; Sugawara S; Endo Y Thromb Haemost; 2009 Dec; 102(6):1251-8. PubMed ID: 19967158 [TBL] [Abstract][Full Text] [Related]
29. Drug-induced alterations in the efflux of 5-hydroxytryptamine and of 5-hydroxyindoleacetic acid into superfusates of the rat spinal cord. Hammond DL; Tyce GM; Yaksh TL Eur J Pharmacol; 1983 Mar; 87(4):441-8. PubMed ID: 6189730 [TBL] [Abstract][Full Text] [Related]
30. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat. Rényi L Br J Pharmacol; 1986 Apr; 87(4):639-48. PubMed ID: 2939912 [TBL] [Abstract][Full Text] [Related]
31. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine. Callahan BT; Yuan J; Ricaurte GA Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894 [TBL] [Abstract][Full Text] [Related]
32. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats. Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591 [TBL] [Abstract][Full Text] [Related]
33. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. Cohen ML; Fuller RW; Kurz KD J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898 [TBL] [Abstract][Full Text] [Related]
34. Metergoline potentiates natural feeding and antagonizes the anorectic action of medical hypothalamic 5-hydroxytryptamine. Currie PJ; Coscina DV Pharmacol Biochem Behav; 1996 Apr; 53(4):1023-8. PubMed ID: 8801574 [TBL] [Abstract][Full Text] [Related]
35. 5HT1A receptor antagonists enhance the functional activity of fluoxetine in a mouse model of feeding. Li DL; Simmons RM; Iyengar S Brain Res; 1998 Jan; 781(1-2):121-8. PubMed ID: 9507085 [TBL] [Abstract][Full Text] [Related]
36. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity. Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549 [TBL] [Abstract][Full Text] [Related]
37. Interactions of 5HT reuptake inhibitors and ethanol in tests of exploration and anxiety. Durcan MJ; Lister RG; Eckardt MJ; Linnoila M Adv Alcohol Subst Abuse; 1988; 7(3-4):113-7. PubMed ID: 3146920 [TBL] [Abstract][Full Text] [Related]
38. Fluoxetine and its two enantiomers as selective serotonin uptake inhibitors. Wong DT; Fuller RW; Robertson DW Acta Pharm Nord; 1990; 2(3):171-80. PubMed ID: 2200429 [TBL] [Abstract][Full Text] [Related]
39. Behavioral interactions of fluoxetine and other 5-hydroxytryptamine uptake inhibitors with ethanol in tests of anxiety, locomotion and exploration. Durcan MJ; Lister RG; Eckardt MJ; Linnoila M Psychopharmacology (Berl); 1988; 96(4):528-33. PubMed ID: 3149776 [TBL] [Abstract][Full Text] [Related]
40. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors. Harrison AA; Markou A J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]